Kai Shu

Tongji Hospital

Papers

2

Total Citations

43

H-Index

2

About

Dr. Kai Shu is a leading neurosurgeon and researcher specializing in minimally invasive neurosurgical robotics, with a particular focus on hypertensive intracerebral hemorrhage (HICH) and brainstem tumor management. His major contributions center on advancing robot-assisted stereotactic techniques to improve precision and safety in complex cranial procedures. In a pivotal 2021 study (25 citations), Dr. Shu demonstrated that combining robot-assisted neuroendoscopic hematoma evacuation with intracranial pressure monitoring significantly enhances clinical outcomes for HICH patients, offering a less invasive alternative to traditional craniotomy. More recently, his 2023 comparative analysis (18 citations) established that the Remebot robot-assisted system achieves comparable safety, efficacy, and accuracy to conventional frame-based stereotaxy for brainstem tumor biopsies, while reducing patient discomfort and operative time. This work is particularly notable for addressing the extreme heterogeneity and surgical challenges of brainstem lesions. Dr. Shu’s research has been instrumental in validating robotic platforms as reliable tools in neurosurgery, bridging the gap between technological innovation and clinical practice. His findings continue to influence protocols for image-guided, frameless stereotactic biopsies, making him a key figure in the evolution of robot-assisted neurosurgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
43
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Neuroendoscopic Hematoma Evacuation Combined Intracranial Pressure Monitoring for the Treatment of Hypertensive Intracerebral Hemorrhage
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Tongji Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago